Senores Pharmaceuticals IPO GMP Today, Senores Pharmaceuticals IPO Grey Market Premium Updates | Senores Pharmaceuticals IPO, Latest target, Opening gain
Senores Pharmaceuticals IPO began on December 20, 2024. It will close on December 24, 2024. The Total IPO Size is ₹ 582.11 Cr Crore Approx. The company set its IPO price is ₹372 to ₹391 per share Per Share. There are three basic categories in Senores Pharmaceuticals IPO Subscription:- 1) Qualified Institutional Buyers. 2) Non-Institutional Investors. 3) Retail.
As of September 30, 2024, the company has launched 55 products in key therapeutic areas, including antibiotics and anti-fungal treatments. They have established partnerships with distributors and hospitals across several states in India.
As of September 30, 2024, the company operates three dedicated R&D facilities in India and the US.
The company’s manufacturing unit is situated in Ahmedabad, Gujrat.
The company’s product portfolio consists of Amphetamine Sulfate Tablets, Hydroxychloroquine Sulfate Tablets, Ketoconazole Tablets, Butalbital, Acetaminophen and Caffeine Capsules, Mexiletine Hydrochloride Capsules, Ketorolac Tromethamine Tablets, Diclofenac Potassium Tablets, Diclofenac Potassium Tablets, Nicardipine Hydrochloride Capsules, Escitalopram Tablets, Prochlorperazine Maleate Tablets USP, Terazosin Capsules USP, Morphine Sulfate Tablets, Methadone Hydrochloride Tablets, Cyclobenzaprine Hydrochloride Tablets, Irbesartan Tablets, Risperidone Tablets Topiramate Capsules, and Ivermectin Tablets for regulated markets.
The company operates in Emerging Markets across 43 countries and manufactures critical care injectables and APIs.
Competitive Strength
- The company serves the US, Canada, and the UK regulated markets with its US FDA-approved manufacturing facility.
- A unique product portfolio tailored for regulated markets developed in a brief period.
- Long-term marketing agreements with pharmaceutical companies in the US, Canada, and the United Kingdom regulated markets.
- Presence in the Emerging Markets with a product portfolio, including speciality or complex products.
- Robust R&D capabilities driving our differentiated portfolio of products.
- Experieced Management Team
Senores Pharmaceuticals IPO Details:
| Issuer | Senores Pharmaceuticals IPO | |
| Issue Type | Book Built Issue IPO | |
| Issue Period | Issue Opens: December 20, 2024 | |
| Issue Closes: December 24, 2024 | ||
| Price Brand | ₹372 to ₹391 per share | |
| Issue Size | ₹ 582.11 Cr | |
| Face Value | ₹10 per share | |
| Market Lot | 38 Shares | |
| Retail (Max) | ₹1,93,154 | |
| QIB | 75% | |
| HNI | 15% | |
| Retail Individual Bidders | 10% | |
| Listing at | NSE & BSE | |
| ✔️ Apply With | ANGEL Free DEMAT Account | |
| Total Shares | Share 1,48,87,723 | |
Senores Pharmaceuticals IPO GMP Rates day by day
Senores Pharmaceuticals IPO Market Lot:
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 38 | ₹14,858 |
| Retail (Max) | 13 | 494 | ₹1,93,154 |
| S-HNI (Min) | 14 | 532 | ₹2,08,012 |
| S-HNI (Max) | 67 | 2,546 | ₹9,95,486 |
| B-HNI (Min) | 68 | 2,584 | ₹10,10,344 |
Senores Pharmaceuticals IPO Date, Allotment & Listing:
| Senores Pharmaceuticals IPO Opening Date: | December 20, 2024 |
| Senores Pharmaceuticals IPO Closing Date: | December 24, 2024 |
| Basis of Allotment: | December 26, 2024 |
| Initiation of Refunds: | December 27, 2024 |
| Credit to Demat Account: | December 27, 2024 |
| Listing Date: | December 30, 2024 |
Senores Pharmaceuticals Limited Financial Information (Restated)
Senores Pharmaceuticals Limited’s revenue increased by 457% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
| Assets | 678.08 | 621.88 | 131.05 | 59.15 | ||||||||||||||||||||||||||||||||||||
| Revenue | 183.35 | 217.34 | 39.02 | 14.63 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 23.94 | 32.71 | 8.43 | 0.99 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 319.06 | 231.71 | 45.5 | 36.59 | ||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 263.36 | 175.94 | 35.25 | 25.37 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 242.03 | 248.38 | 60.76 | 14.21 | ||||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
The market capitalization of Senores Pharmaceuticals IPO is Rs 1350.70 Cr.
KPI as of Sun, Mar 31, 2024.
| KPI | Values |
|---|---|
| ROE | 23.60% |
| ROCE | 11.73% |
| Debt/Equity | 1.07 |
| RoNW | 23.60% |
| PAT Margin | 15.25 |
| Price to Book Value | 5.84 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 9.83 | 13.86 |
| P/E (x) | 39.77 | 28.21 |
Objects of the Issue (Senores Pharmaceuticals IPO Objectives)
Senores Pharmaceuticals IPO ALLOTMENT STATUS
How to Apply for Senores Pharmaceuticals IPO?
If you’re a new investor Open a DEMAT Account for free with Angel One and build wealth with the best stock choices. Join a 1 million+ family of happy customers.
How to Apply Senores Pharmaceuticals IPO through Zerodha?
Log in to the Console in the Zerodha Website or Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Senores Pharmaceuticals”. Click on the Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open a Demat Account with Zerodha.
How to Apply Senores Pharmaceuticals IPO through Upstox?
Log in to the Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Senores Pharmaceuticals”. Click on the Bid Button. Confirm your application. Now go to your UPI App on Net Banking or BHIM App to Approve – the mandate. Open a Demat Account with Upstox.
In case you have not been allotted or for any partial allotment of IPO shares, the blocked amount, if any, will be unblocked/released on or before the UPI mandate expiry date. Please reach out to your bank in case funds are not unblocked/released after the mandate expiry date. 
PARENT COMPANY FOR SHAREHOLDER QUOTA
IPO ALLOTMENT TIPS & TRICKS
Frequently Asked Questions
What is Senores Pharmaceuticals IPO?
Senores Pharmaceuticals IPO is a main-board initial public offering of 1,48,87,723 Equity shares of the face value of ₹10 aggregating up to ₹582.11 Crores. The issue price of the IPO is ₹372 to ₹391 Per Equity Share. The minimum order quantity is 38 Shares per application and the offer type is Book Built Issue. The IPO opens on December 20, 2024 and closes on December 24, 2024. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Senores Pharmaceuticals IPO opens on December 20, 2024 and closes on December 24, 2024
How to apply for Senores Pharmaceuticals IPO?
You can apply in Senores Pharmaceuticals IPO online using either UPI or ASBA as payment method. Equirus Capital Private Limited, Ambit Private Limited, Nuvama Wealth Management Limited are the book running lead managers of the Senores Pharmaceuticals IPO, while Link Intime India Private Ltd is the registrar for the issue.
When Senores Pharmaceuticals IPO allotment?
The finalization of Basis of Allotment for Senores Pharmaceuticals IPO will be done on December 26, 2024 and the allotted shares will be credited to your demat account by December 27, 2024
Check the Senores Pharmaceuticals IPO allotment status.
When is Senores Pharmaceuticals IPO listing date?
The Senores Pharmaceuticals IPO listing date is not yet announced. The tentative date of Senores Pharmaceuticals IPO listing is December 30, 2024.
What is the lot size of Senores Pharmaceuticals IPO?
Senores Pharmaceuticals lot size is 38 Shares and the minimum order quantity is 1 Share.